SECURITIES AND EXCHANGE COMMISSIONSEC FORM 17-C

CURRENT REPORT UNDER SECTION 17
OF THE SECURITIES REGULATION CODE
AND SRC RULE 17.2(c) THEREUNDER

1. Date of Report (Date of earliest event reported)

Jan 30, 2022

2. SEC Identification Number

808

3. BIR Tax Identification No.

000-162-935

4. Exact name of issuer as specified in its charter

DITO CME HOLDINGS CORP.

5. Province, country or other jurisdiction of incorporation

Philippines

6. Industry Classification Code(SEC Use Only)

7. Address of principal office

21st Floor, Udenna Tower, Rizal Drive corner 4th Avenue, Bonifacio Global City, Taguig City Postal Code 1634

8. Issuer's telephone number, including area code

+63284034007

9. Former name or former address, if changed since last report

n/a

10. Securities registered pursuant to Sections 8 and 12 of the SRC or Sections 4 and 8 of the RSA

Title of Each Class	Number of Shares of Common Stock Outstanding and Amount of Debt Outstanding
Common	14,035,000,000

11. Indicate the item numbers reported herein

Item 9

The Exchange does not warrant and holds no responsibility for the veracity of the facts and representations contained in all corporate disclosures, including financial reports. All data contained herein are prepared and submitted by the disclosing party to the Exchange, and are disseminated solely for purposes of information. Any questions on the data contained herein should be addressed directly to the Corporate Information Officer of the disclosing party.

DITO CME Holdings Corp.DITO

PSE Disclosure Form 4-14 - Stock Rights Offering References: SRC Rule 17 (SEC Form 17-C) and
Section 4.4 of the Revised Disclosure Rules

Subject of the Disclosure
Updates on the Stock Rights Offering of Dito CME Holdings, Inc. (the "Company")
Background/Description of the Disclosure
With reference to the Listing Notices of the PSE (Listing Notices LN00396-2021 dated December 20, 2021, LN00014-2022 dated January 14, 2022, and LN00031-2022), DITO CME Holdings Corp. (the "Company"), please note that as an update, the Company has notified the PSE of its deferment of the Stock Rights Offer due to the less than ideal market conditions and other perceived risks. In lieu of this, the Company is studying several alternative financing proposals recently made available which it sees to be more value-enhancing to its shareholders. When conditions improve, the Company may return to the market. Thus, please be advised that the Company shall refund any and all subscription payments made by any existing shareholder or qualified institutional buyer during the offer period of the Stock Rights Offer. Also, in connection with the Company’s notice of the deferment of the SRO, the PSE issued notice LN00031-2022 dated January 29,2022, which provides that the PSE, as a self-regulatory organization, shall ensure that there is full compliance with the applicable rules and for the protection of the investing public, consistent with the mandate of the exchange, to maintain a fair and orderly market.

Date of Approval by Board of Directors	Aug 26, 2021
Entitlement Ratio	TBA
Offer Price	TBA
Number of Shares to be Offered	TBA
Ex-Rights Date	TBA
Record Date	TBA
Start of Offer Period	TBA
End of Offer Period	TBA

Use of Proceeds
Due to the deferment of the Stock Rights Offer, the use of proceeds shall be inapplicable at this time.
Other Relevant Information
Please see attached press release on the deferment of the Stock Rights Offer.